ECL Ecolab Inc.
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.…
Industry Peers
Specialty ChemicalsKey Statistics
About Ecolab (NYSE: ECL)
›
Ecolab (NYSE: ECL) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 48,000 employees.
The shares were at 297.42 USD on 19 November 2026, up 17.1% over 52 weeks. Its 52-week range is 243.15 USD to 318.93 USD: the price is 6.7% below the high and 22.3% above the low.
At a market capitalisation of 83.39B USD, it trades at 40.5 times trailing earnings and 31.4 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 32.8, a premium of 23% for ECL. It pays a dividend yielding 0.97% (it pays out 40% of its earnings), against a median of 1.91% among the dividend payers in that peer group.
Ecolab reports return on equity of 21.2%, an operating margin of 18.5% and revenue up 12.7% year over year.
Its debt exceeds its cash by 13.22B USD, a debt-to-equity ratio of 0.92. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 21 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 342.95 USD is 15.3% above the current price. The next earnings report is expected on 9 February 2027.